Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
WSTWest Pharmaceutical Services
FinDog View：Neutral
| Metric | LLY | WST |
|---|
| Close | 1,137.82 | 362.01 |
| Market Cap | $1.07T | $23.9B |
| 1M | −3.83% | +4.44% |
| P/E (TTM) | 39.9 | 43.1 |
| Forward P/E | 28.5 | 36.0 |
| P/E 5-Yr Percentile | 6 | 49 |
| P/S | 13.4 | 7.3 |
| P/B | 31.5 | 8.2 |
| Dividend Yield | 0.75% | 0.33% |
| Latest Quarter Revenue | $23.0B | $872M |
| Revenue YoY | +47.7% | +13.8% |
| Gross Margin | 85.8% | 37.7% |
| Latest Quarter EPS | 7.94 | 2.15 |
| Avg Post-Earnings Move | ±3.5% | ±3.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 1 / 1 |
| Shareholder Yield | 1.12% | 2.16% |
| 90-Day Net Insider Buying | −$16.0M | −$5.4M |
LLY · Revenue, Last 8 Quarters ($B)
WST · Revenue, Last 8 Quarters ($B)
